Prevalence of HBV markers in the Italian Armed Forces and HBV vaccination.
Hepatitis B (HBV) markers were studied in 710 subjects who had been on active duty for over 6 months in the Italian Armed Forces. The prevalence of HBsAg carriers was found to be 4.4%, while 31.6% of the subjects were positive for various HBV antibodies. A total of 137 subjects were vaccinated with an anti-HBV vaccine (HB-VAX, MSD). The percentages of non-responders and low responders were 13.86% and 13.14%, respectively. Boosters administered 3 months post-vaccination schedule, with or without immunostimulatory treatment, resulted in seroconversions and/or substantial increases in HBsAb levels in 50% of these subjects.
D'Amelio
R
R
Matricardi
P M
PM
Nisini
R
R
Le Moli
S
S
Fattorossi
A
A
Di Addario
A
A
Castagliuolo
P P
PP
D000293:Adolescent; D000328:Adult; D002353:Carrier State / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000032:analysis* / Q000276:immunology; D006511:Hepatitis B Antigens / Q000032:analysis* / Q000276:immunology; D017325:Hepatitis B Vaccines; D006801:Humans; D007115:Immunization Schedule; D007558:Italy; D008297:Male; D008875:Middle Aged; D008889:Military Personnel; D014761:Viral Hepatitis Vaccines / Q000276:immunology*
D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines